Colorectal Cancer

Researchers found that cannabinoids did not appear to reduce cancer-related pain in adults. It was the week’s top story in hematology/oncology.

A computer-aided colonoscopy system helped detect adenomas that were initially missed by the endoscopist, according to study results.

One of the top stories in gastroenterology last week was about a double-blind, randomized clinical trial that showed the Chinese herb Coptis chinensis reduced the risk for recurrent colorectal adenoma.

A steep increase in incidence of colorectal cancer among patients aged between 49 and 50 years may suggest that many cases go undetected in younger patients before they reach routine, average-risk screening at age 50 years, according to data published in JAMA Network Open.

Insight into how clinicians can integrate belief in miracles into their discussions with terminally ill patients with advanced cancer was the top story in hematology/oncology last week.

Fusobacterium nucleatum may be partially responsible for the sharp increase in colorectal cancer incidence among individuals aged younger than 45 years, according to preliminary results of an ongoing study presented at Gastrointestinal Cancers Symposium.

An investigational blood-based assay demonstrated efficacy in detecting multiple types of cancer, including gastrointestinal cancers, at various stages, according to study results presented at Gastrointestinal Cancers Symposium.

Berberine, a supplement originally extracted from the Chinese herb Coptis chinensis, helped to reduce risk for recurrent colorectal adenoma, according to study results.

Patients at low and intermediate risk for colorectal cancer may not require postpolypectomy surveillance, according to research published in Gut.

Young adults with colorectal cancer who resided in areas with the lowest incomes and high school graduation rates had a 24% increased risk for death than their counterparts in areas with the highest incomes and graduation rates, according to study results scheduled for presentation at Gastrointestinal Cancers Symposium.